Lydimycin
Lydimycin (α-DHB; α-Dehydrobiotin) is an antibiotic produced by Streptomyces lydicus, with antibacterial, antifungal and antiviral activities. Lydimycin inhibits the binding of SARS-CoV-2 S-614G spike protein to human ACE2. The antibacterial activity of Lydimycin can be reversed by Biotin (HY-B0511) in the culture medium. Lydimycin is applicable to infection-related research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 10118-85-1
- 화학식: C10H14N2O3S
- 분자량:242.29
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Antibiotic Isoforms
More
Biological Activity
제품 설명
IC50 & Target
Bacterial[1]
In Vitro
Lydimycin (compound Ⅰ) displays broad-spectrum in vitro antimicrobial activity against diverse gram-positive bacteria, gram-negative bacteria, and fungi[1].
Lydimycin (1.25-20.0 μg) inhibits Escherichia coli growth in a synthetic medium in a dose-dependent manner, with its antibacterial activity reversed by increasing concentrations of biotin, showing no inhibition at 0.100 μg/mL Biotin (HY-B0511) across all tested doses[1].
Lydimycin (0-200 μM) inhibits the binding of SARS-CoV-2 S-614G-Strep spike protein to human ACE2-Fc with an IC50 of 1.6 μM, without non-specific Alpha signal interference[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 10118-85-1
-
분자량 242.29
-
화학식 C10H14N2O3S
-
SMILES
C(C/C=C/C(O)=O)[C@H]1[C@@]2([C@@](NC(=O)N2)(CS1)[H])[H]
-
Synonyms
α-DHB; α-Dehydrobiotin
-
Structure Classification
-
Initial Source
Streptomyces lydicus
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)